The Inflammatory Profile of the Tumor Microenvironment, Orchestrated by Cyclooxygenase-2, Promotes Epithelial-Mesenchymal Transition

被引:52
作者
Gomez-Valenzuela, Fernan [1 ]
Escobar, Enrico [2 ]
Perez-Tomas, Ricardo [3 ]
Montecinos, Viviana P. [1 ]
机构
[1] Pontificia Univ Catolica Chile, Dept Hematol Oncol, Santiago, Chile
[2] Univ Chile, Fac Dent, Dept Oral Pathol & Med, Santiago, Chile
[3] Univ Barcelona, Fac Med & Hlth Sci, Dept Pathol & Expt Therapy Bellvitge, Barcelona, Spain
关键词
tumor microenvironment; cyclooxygenase-2; epithelial-mesenchymal transition; cancer; inflammation; BREAST-CANCER CELLS; SIGNALING PATHWAY; PANCREATIC-CANCER; PD-L1; EXPRESSION; COX-2; LUNG-CANCER; E-CADHERIN; EMT; MACROPHAGES; GROWTH;
D O I
10.3389/fonc.2021.686792
中图分类号
R73 [肿瘤学];
学科分类号
100214 ;
摘要
The tumor microenvironment (TME) corresponds to a complex and dynamic interconnection between the extracellular matrix and malignant cells and their surrounding stroma composed of immune and mesenchymal cells. The TME has constant cellular communication through cytokines that sustain an inflammatory profile, which favors tumor progression, angiogenesis, cell invasion, and metastasis. Although the epithelial-mesenchymal transition (EMT) represents a relevant metastasis-initiating event that promotes an invasive phenotype in malignant epithelial cells, its relationship with the inflammatory profile of the TME is poorly understood. Previous evidence strongly suggests that cyclooxygenase-2 (COX-2) overexpression, a pro-inflammatory enzyme related to chronic unresolved inflammation, is associated with common EMT-signaling pathways. This review article summarizes how COX-2 overexpression, within the context of the TME, orchestrates the EMT process and promotes initial metastatic-related events.
引用
收藏
页数:16
相关论文
共 150 条
[1]   Interplay between tumor microenvironment and partial EMT as the driver of tumor progression [J].
Aggarwal, Vaishali ;
Montoya, Catalina Ardila ;
Donnenberg, Vera S. ;
Sant, Shilpa .
ISCIENCE, 2021, 24 (02)
[2]   Overexpression of COX2 indicates poor survival in urothelial bladder cancer [J].
Agrawal, Usha ;
Kumari, Nitu ;
Vasudeva, Pawan ;
Mohanty, Nayan K. ;
Saxena, Sunita .
ANNALS OF DIAGNOSTIC PATHOLOGY, 2018, 34 :50-55
[3]   EMT or EMT-promoting transcription factors, where to focus the light? [J].
Ansieau, Stephane ;
Colli, Guillaume ;
Hill, Louise .
FRONTIERS IN ONCOLOGY, 2014, 4
[4]   TAMeless traitors: macrophages in cancer progression and metastasis [J].
Aras, Shweta ;
Zaidi, M. Raza .
BRITISH JOURNAL OF CANCER, 2017, 117 (11) :1583-1591
[5]   Clinical significance of interleukin-6 (IL-6) in the spread of gastric cancer: Role of IL-6 as a prognostic factor [J].
Ashizawa T. ;
Okada R. ;
Suzuki Y. ;
Takagi M. ;
Yamazaki T. ;
Sumi T. ;
Aoki T. ;
Ohnuma S. ;
Aoki T. .
Gastric Cancer, 2005, 8 (2) :124-131
[6]   Tumor microenvironment complexity and therapeutic implications at a glance [J].
Baghba, Roghayyeh ;
Roshangar, Leila ;
Jahanban-Esfahlan, Rana ;
Seidi, Khaled ;
Ebrahimi-Kalan, Abbas ;
Jaymand, Mehdi ;
Kolahian, Saeed ;
Javaheri, Tahereh ;
Zare, Peyman .
CELL COMMUNICATION AND SIGNALING, 2020, 18 (01)
[7]   EMT, MET, Plasticity, and Tumor Metastasis [J].
Bakir, Basil ;
Chiarella, Anna M. ;
Pitarresi, Jason R. ;
Rustgi, Anil K. .
TRENDS IN CELL BIOLOGY, 2020, 30 (10) :764-776
[8]   Coexpression of NOS2 and COX2 accelerates tumor growth and reduces survival in estrogen receptor-negative breast cancer [J].
Basudhar, Debashree ;
Glynn, Sharon A. ;
Greer, Madison ;
Somasundaram, Veena ;
No, Jae Hong ;
Scheiblin, David A. ;
Garrido, Pablo ;
Heinz, William F. ;
Ryan, Aideen E. ;
Weiss, Jonathan M. ;
Cheng, Robert Y. S. ;
Ridnour, Lisa A. ;
Lockett, Stephen J. ;
McVicar, Daniel W. ;
Ambs, Stefan ;
Wink, David A. .
PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA, 2017, 114 (49) :13030-13035
[9]   Biology and therapeutic targeting of tumour-associated macrophages [J].
Beltraminelli, Tim ;
De Palma, Michele .
JOURNAL OF PATHOLOGY, 2020, 250 (05) :573-592
[10]   Effect of Concurrent Chemoradiation With Celecoxib vs Concurrent Chemoradiation Alone on Survival Among Patients With Non-Small Cell Lung Cancer With and Without Cyclooxygenase 2 Genetic Variants A Phase 2 Randomized Clinical Trial [J].
Bi, Nan ;
Liang, Jun ;
Zhou, Zongmei ;
Chen, Dongfu ;
Fu, Zhixue ;
Yang, Xu ;
Feng, QinFu ;
Hui, Zhouguang ;
Xiao, Zefen ;
Lv, Jima ;
Wang, Xiaozhen ;
Zhang, Tao ;
Wang, Xin ;
Deng, Lei ;
Wang, Wenqing ;
Wang, Jingbo ;
Liu, Lipin ;
Hu, Chen ;
Wang, Luhua .
JAMA NETWORK OPEN, 2019, 2 (12)